TIFFANY WILLIAMS: Open Payments
NPI 1447902168 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 39 payments from 9 companies in 2025. Trend: 2023 $593 · 2024 $1,229 · 2025 $809
Food & beverage: $809
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $209 |
| GENZYME CORPORATION | 4 | $137 |
| UCB, Inc. | 7 | $129 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $112 |
| Lilly USA, LLC | 3 | $76 |
| Janssen Biotech, Inc. | 4 | $72 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
Products named: DUPIXENT, RINVOQ, Bimzelx, ILUMYA, SKYRIZI, TALTZ, TREMFYA, COSENTYX.
Industry payments across AR — which companies pay providers there.
